{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:50:38Z","timestamp":1780447838439,"version":"3.54.1"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":180,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/dth.12217","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T04:47:18Z","timestamp":1425617238000},"page":"243-247","source":"Crossref","is-referenced-by-count":22,"title":["Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream"],"prefix":"10.1155","volume":"28","author":[{"given":"Jian-Qiang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Dermatology; Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou Zhejiang China"},{"name":"Department of Dermatology; First Affiliated Hospital of Huzhou University; Huzhou Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Yongkang Hospital of Traditional Chinese Medicine; Yongkang Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Yixiao","family":"Engle","sequence":"additional","affiliation":[{"name":"Family Medicine Resident; O'Connor Hospital; San Jose CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-You","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou Zhejiang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"10.1111\/dth.12217-BIB0001|dth12217-cit-0001","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a light on xeroderma pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12217-BIB0002|dth12217-cit-0002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-6-70","article-title":"Xeroderma pigmentosum","volume":"6","author":"Lehmann","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/dth.12217-BIB0003|dth12217-cit-0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0781.2001.017002047.x","article-title":"Xeroderma pigmentosum - bridging a gap between clinic and laboratory","volume":"17","author":"Moriwaki","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/dth.12217-BIB0004|dth12217-cit-0004","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2133.2003.05613.x","article-title":"Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream","volume":"149","author":"Nagore","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12217-BIB0005|dth12217-cit-0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09546634.2010.548503","article-title":"Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review","volume":"22","author":"Lacarrubba","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/dth.12217-BIB0006|dth12217-cit-0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(99)00088-2","article-title":"Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum","volume":"23","author":"Cleaver","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1111\/dth.12217-BIB0007|dth12217-cit-0007","doi-asserted-by":"crossref","first-page":"534752","DOI":"10.1155\/2013\/534752","article-title":"Xeroderma pigmentosum: man deprived of his right to light","volume":"2013","author":"Mareddy","year":"2013","journal-title":"Scientificworldjournal"},{"key":"10.1111\/dth.12217-BIB0008|dth12217-cit-0008","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2012.04628.x","article-title":"High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases","volume":"27","author":"Wolberink","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12217-BIB0009|dth12217-cit-0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1470-2045(13)70582-5","article-title":"Evidence-based treatment for low-risk basal cell carcinoma","volume":"15","author":"Lear","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1111\/dth.12217-BIB0010|dth12217-cit-0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1111\/dth.12217-BIB0011|dth12217-cit-0011","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1111\/dth.12217-BIB0012|dth12217-cit-0012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjd.12402","article-title":"Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC","volume":"169","author":"McKay","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12217-BIB0013|dth12217-cit-0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000345763","article-title":"Facial basal cell carcinomas recurring after imiquimod therapy","volume":"226","author":"Skaria","year":"2013","journal-title":"Dermatology"},{"key":"10.1111\/dth.12217-BIB0014|dth12217-cit-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D36DM013FJ","article-title":"Local reactions to imiquimod in the treatment of basal cell carcinoma","volume":"18","author":"Tandon","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1111\/dth.12217-BIB0015|dth12217-cit-0015","first-page":"518","article-title":"Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream","volume":"28","author":"Weisberg","year":"2002","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12217","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12217\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:21:12Z","timestamp":1747768872000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12217"}},"subtitle":["Topical imiquimod: effective for BCC"],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12217","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}